Arvilap
Arvilap
Authorised
- Rabbit haemorrhagic disease virus, strain VHD-1, Inactivated
Product identification
Medicine name:
Arvilap
Active substance:
- Rabbit haemorrhagic disease virus, strain VHD-1, Inactivated
Target species:
-
Rabbit
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabbit haemorrhagic disease virus, strain VHD-1, Inactivated160.00/haemagglutination inhibiting unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Rabbit
-
Meat and offalno withdrawal periodzero days
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI08AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Laboratorios Ovejero S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Ovejero S.A.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 7985
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Dutch (PDF)
Published on: 28/02/2022
How useful was this page?:
